Sumitomo Dainippon Pharma : announces Organizational Realignment and Changes in Executive Officers and Other Key Positions

ene20151201.pdf

December 1, 2015 Sumitomo Dainippon Pharma Co., Ltd.

Sumitomo Dainippon Pharma announces Organizational Realignment and Changes in Executive Officers and Other Key Positions

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) today announced that the following organizational realignment and changes in Executive Officers and other key positions will take place effective January 1, 2016:

1. Organizational Realignment (effective January 1, 2016)

   
   

   Corporate Departments

2. Oncology Clinical Development Unit is created.

3. Oncology Medical & Marketing Unit is created.

   
   

   Drug Development (Division)

   Oncology Clinical Development Unit is dissolved.

   
   

   Sales & Marketing (Division)

   Oncology Marketing Unit is dissolved.

   
   

4. Changes in Executive Officers




Changes in the posts assumed by Executive Officers (effective January 1, 2016)




Post as of January 1, 2016	Current post	Name
Representative Director, President and Chief Executive Officer	Representative Director, President and Chief Executive Officer Executive Director, Drug Development	Masayo Tada
Member,Board of Directors, Senior Executive Officer Global Corporate Planning; Global Business Development; External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting; Regenerative & Cellular Medicine Office; Drug Development	Member,Board of Directors, Senior Executive Officer Global Corporate Planning; Global Business Development; External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting; Regenerative & Cellular Medicine Office	Hiroshi Nomura
Executive Officer Executive Director, Drug Development	Executive Officer Deputy Executive Director, Drug Development	Nobuyuki Hara







II. Changes in Personnel (effective January 1, 2016)







Position as of January 1, 2016	Current position	Name
Director, Drug Development Research Laboratories Director, Preclinical Research Laboratories	Director, Drug Development Research Laboratories	Isao Shimizu
Director, Oncology Clinical Development Unit	Director, Oncology Clinical Development Unit	Haruhiko Koike
Director, Oncology Medical & Marketing Unit	Director, Oncology Marketing Unit	Masayuki Uchibori
Director, Manufacturing Management Director, Procurement	Director, Ibaraki Plant	Kenji Ueno
Director, Ibaraki Plant	Director, Manufacturing Technology	Hiroyuki Nishii
Director, Manufacturing Technology	Group Manager, Pharmaceutical Technology Suzuka Group	Mitsuhito Kondo







Contact:

Corporate Communications Sumitomo Dainippon Pharma TEL: +81-6-6203-1407 (Osaka)

+81-3-5159-3300 (Tokyo)